YU120491A - Benzacetamidni derivati - Google Patents

Benzacetamidni derivati

Info

Publication number
YU120491A
YU120491A YU120491A YU120491A YU120491A YU 120491 A YU120491 A YU 120491A YU 120491 A YU120491 A YU 120491A YU 120491 A YU120491 A YU 120491A YU 120491 A YU120491 A YU 120491A
Authority
YU
Yugoslavia
Prior art keywords
group
alkyl
represent hydrogen
halogen
independently
Prior art date
Application number
YU120491A
Other languages
English (en)
Inventor
G.H.P. An Daele
M.G.C. Verdonck
J.P.R.M.A. Bosmans
P.A.J. Janssen
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Priority to SI9111204A priority Critical patent/SI9111204A/sl
Priority to HR930485A priority patent/HRP930485A2/xx
Publication of YU120491A publication Critical patent/YU120491A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/40—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C327/44—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/48—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Naziv: Benzacetamidni derivati formule njegova farmaceutski prihvatljiva adiciona so sa kiselinom ili njegov stereohemijski izomeran oblik, u kome R1 i R2, nezavisno jedna od druge predstavljaju vodonik, C1-6-alkil ili C3-6-cikloalkil grupu; ili R1 i R2 zajedno sa atomom azota, za koji su vezani mogu lako da obrazuju pirolidinilnu, piperidinilnu, morfolinilnu, piperazinilnu ili 4-C1-4-alkilpipererazinilnu grupu; X je O ili S; R3 je vodonik ili C1-6-alkil grupa; R4, R5 i R6, nezavisno jedna od druge predstavljaju vodonik, halogen, C1-6-alkil, C1-6-alkiloksi, nitro, trifluormetil, cijano, aminometil, karboksil, C1-4-alkiloksikarbonil, C1-4-alkilkarbonil, aminokarbonil ili hidroksi grupu; R7 je vodonik ili halogen; a R8, R9 i R10, nezavisno jedna od druge predstavljaju vodonik, halogen, C1-6-alkil, C1-6-alkiloksi, nitro, hidroksi, trifluormetoksi, 2,2,2-trifluoretoksi, (trifluormetil) karbonil, aminokarbonil, (cik-lopropil) karbonil grupu ili ostatak C1-6-alkil-(C=Y)-u kome =Y označava =O, =N-OH, =N-OCH3, =N-NH2 ili =N-N(CH3)2; pod uslovom da je: (1) R1 različito od n- propila kada R2, R3, R4, R5, R6, R7, R9 i R10 predstavljaju vodonik, a da R8 označava 4-etoksi grupu, a X označava kiseonik, i (2) X različito od sumpora, kada R1, R2, R3, R6, R7, R8, R9 i R10 predstavljaju vodonik, a R4 i R5 označavaju 3,4-dimetoksi grupu. Nova jedinjenja, farmaceutskih sastava koji sadrže pomenuta jedinjenja formule (I) i postupci za pripremanje pomenutih sastava.
YU120491A 1990-07-10 1991-07-08 Benzacetamidni derivati YU120491A (sh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SI9111204A SI9111204A (en) 1990-07-10 1991-07-08 Hiv-inhibiting benzenacetamide derivatives
HR930485A HRP930485A2 (en) 1990-07-10 1993-03-23 Hiv-inhibiting benzenacetamide derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90201857 1990-07-10
EP91200646 1991-03-22

Publications (1)

Publication Number Publication Date
YU120491A true YU120491A (sh) 1994-06-10

Family

ID=26125946

Family Applications (1)

Application Number Title Priority Date Filing Date
YU120491A YU120491A (sh) 1990-07-10 1991-07-08 Benzacetamidni derivati

Country Status (42)

Country Link
US (2) US5556886A (sh)
EP (1) EP0538301B1 (sh)
JP (1) JPH0819068B2 (sh)
KR (1) KR0183446B1 (sh)
CN (2) CN1028990C (sh)
AP (1) AP311A (sh)
AT (1) ATE144765T1 (sh)
AU (1) AU643056B2 (sh)
BG (1) BG61809B1 (sh)
CA (1) CA2084508A1 (sh)
CZ (1) CZ279901B6 (sh)
DE (1) DE69122963T2 (sh)
DK (1) DK0538301T3 (sh)
DZ (1) DZ1514A1 (sh)
ES (1) ES2095942T3 (sh)
FI (1) FI930070A (sh)
GR (1) GR3021829T3 (sh)
HR (1) HRP930485A2 (sh)
HU (2) HUT64013A (sh)
IE (1) IE75693B1 (sh)
IL (3) IL98756A (sh)
LT (1) LT3602B (sh)
LV (1) LV10086B (sh)
MA (1) MA22208A1 (sh)
MX (1) MX9100100A (sh)
MY (1) MY108580A (sh)
NO (1) NO303777B1 (sh)
NZ (1) NZ238763A (sh)
OA (1) OA09770A (sh)
PH (1) PH30977A (sh)
PL (1) PL167076B1 (sh)
PT (1) PT98259B (sh)
RO (1) RO112855B1 (sh)
RU (1) RU2087465C1 (sh)
SG (1) SG48829A1 (sh)
SI (1) SI9111204A (sh)
SK (1) SK279639B6 (sh)
TN (1) TNSN91056A1 (sh)
TW (1) TW204337B (sh)
WO (1) WO1992000952A1 (sh)
YU (1) YU120491A (sh)
ZA (1) ZA915334B (sh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407961A (en) * 1991-12-30 1995-04-18 Janssen Pharmaceutica N.V. α-substituted benzenemethanamine derivatives and pharmaceutical use
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
ATE141254T1 (de) * 1992-07-06 1996-08-15 American Cyanamid Co O-nitrophenyl cyclopropyl keton, herbizides zwischenprodukt und verfahren zu seiner herstellung
EP0684818B1 (en) * 1993-02-22 1999-05-06 Janssen Pharmaceutica N.V. Method of reversing resistance of hiv-1 strains to zidovudine
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
GB9403449D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
GB9403408D0 (en) * 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
IL112739A0 (en) * 1994-02-23 1995-05-26 Wellcome Found Ayrlthiobenzonitrile compounds, their preparation and pharmaceutical compositions containing them
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
EP0872233A1 (en) * 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
BR9911385A (pt) * 1998-06-19 2001-03-13 Us Health Composição, processos para dissociar um ìon de metal de uma proteìna contendo dedo de zinco, para inativar um vìrus e para selecionar um composto capaz de dissociar um ìon de metal quelado com um dedo de zinco de uma proteìna viral, vìrus isolado e inativado, kit para selecionar um composto capaz de dissociar um ìon de metal de um dedo de zinco de uma proteìna viral, composição viricida, e, formulação farmacêutica.
IL148801A0 (en) 1999-09-24 2002-09-12 Janssen Pharmaceutica Nv Antiviral compositions
JP4713026B2 (ja) * 2000-08-11 2011-06-29 日本たばこ産業株式会社 カルシウム受容体拮抗薬
DE60136187D1 (de) * 2000-08-11 2008-11-27 Japan Tobacco Inc Calciumrezeptor-antagonisten
DK1742908T3 (da) * 2004-04-23 2010-01-18 Hoffmann La Roche Ikke nukleosid revers transkriptase inhibitorer
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
EP2061756B1 (en) * 2006-06-08 2013-09-25 Bristol-Myers Squibb Company 2-aminocarbonylphenylamino-2-phenilacetamides as factor viia inhibitors useful as anticoagulants
RU2449985C2 (ru) * 2010-03-31 2012-05-10 Федеральное государственное унитарное предприятие "Российский научный центр "Прикладная химия" Способ получения n,n-диметилацетамида
CN102675212B (zh) * 2012-05-09 2014-11-05 昆明理工大学 N-取代苯基-2-((1h-苯并咪唑-2-基)巯基)乙酰胺类衍生物及其用途
CN104000807B (zh) * 2014-05-28 2016-05-18 中山大学 苯基-酰胺类化合物在制备抗hiv-1病毒药物中的应用
CN105367437B (zh) * 2015-10-12 2017-08-01 湖北文理学院 一种2‑芳氨基乙酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1423430A (en) * 1973-03-29 1976-02-04 Wyeth John & Brother Ltd Thioamides
US4246429A (en) * 1978-06-23 1981-01-20 Janssen Pharmaceutica, N.V. Novel α-amino-phenylacetic acid derivatives
CH637828A5 (en) * 1978-11-15 1983-08-31 Koehler Franz Dr Chemie Kg Cytostatics
US5407961A (en) * 1991-12-30 1995-04-18 Janssen Pharmaceutica N.V. α-substituted benzenemethanamine derivatives and pharmaceutical use

Also Published As

Publication number Publication date
PL297608A1 (sh) 1992-07-13
DZ1514A1 (fr) 2004-09-13
NO930047L (no) 1993-01-07
MA22208A1 (fr) 1992-04-01
RU2087465C1 (ru) 1997-08-20
LT3602B (en) 1995-12-27
ES2095942T3 (es) 1997-03-01
SI9111204A (en) 1995-04-30
TNSN91056A1 (fr) 1992-10-25
EP0538301B1 (en) 1996-10-30
LTIP848A (en) 1995-02-27
ZA915334B (en) 1993-03-31
PT98259A (pt) 1992-04-30
CN1028990C (zh) 1995-06-21
AP9100288A0 (en) 1991-07-31
GR3021829T3 (en) 1997-02-28
IL98756A0 (en) 1992-07-15
HUT64013A (en) 1993-11-29
IL111924A0 (en) 1995-03-15
HRP930485A2 (en) 1996-06-30
CS210291A3 (en) 1992-02-19
IE912208A1 (en) 1992-01-15
MY108580A (en) 1996-10-31
PH30977A (en) 1997-12-23
NO303777B1 (no) 1998-08-31
IL98756A (en) 1996-06-18
IL111924A (en) 1996-12-05
CA2084508A1 (en) 1992-01-11
NO930047D0 (no) 1993-01-07
BG97265A (bg) 1994-03-24
AU8212091A (en) 1992-02-04
IE75693B1 (en) 1997-09-10
NZ238763A (en) 1993-10-26
CN1033142C (zh) 1996-10-30
PT98259B (pt) 1998-12-31
LV10086A (lv) 1994-05-10
JPH0819068B2 (ja) 1996-02-28
CN1058958A (zh) 1992-02-26
RO112855B1 (ro) 1998-01-30
MX9100100A (es) 1992-02-28
AP311A (en) 1994-02-01
DK0538301T3 (da) 1996-11-25
KR0183446B1 (ko) 1999-05-15
FI930070A0 (fi) 1993-01-08
CN1107835A (zh) 1995-09-06
WO1992000952A1 (en) 1992-01-23
ATE144765T1 (de) 1996-11-15
AU643056B2 (en) 1993-11-04
PL167076B1 (pl) 1995-07-31
SG48829A1 (en) 1998-05-18
DE69122963T2 (de) 1997-03-13
TW204337B (sh) 1993-04-21
SK210291A3 (en) 1995-07-11
OA09770A (fr) 1993-11-30
FI930070A (fi) 1993-01-08
CZ279901B6 (cs) 1995-08-16
LV10086B (en) 1995-02-20
BG61809B1 (bg) 1998-06-30
EP0538301A1 (en) 1993-04-28
DE69122963D1 (de) 1996-12-05
JPH05507931A (ja) 1993-11-11
HU211873A9 (en) 1995-12-28
HU9300032D0 (en) 1993-04-28
SK279639B6 (sk) 1999-01-11
US5556886A (en) 1996-09-17
US5684049A (en) 1997-11-04

Similar Documents

Publication Publication Date Title
YU120491A (sh) Benzacetamidni derivati
AR088808A2 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
AR037534A1 (es) Derivado de adamantano, su uso en la fabricacion de un medicamento para usar en terapia, composicion farmaceutica, proceso para la preparacion de dicho compuesto y dicha composicion y compuestos intermediarios
AR102722A2 (es) Un derivado de pirazolo-quinazolina, su uso, un procedimiento para prepararlos, composiciones farmacéuticas que los comprenden, compuestos utilizables en su preparación, una biblioteca de dos o más compuestos, y un producto o kit
AR039565A1 (es) Derivados de piperazinilo, piperidinilo y morfolinilo como inhibidores de desacetilasa de histona, composicion farmaceutica que los contiene y procedimiento de preparacion de ambos
RU92016592A (ru) Вич ингибирующие бензолацетамидные производные
NO305209B1 (no) N-alkyl-2-substituerte ATP-analoger, slike forbindelser til fremstilling av terapeutikum, farmas°ytisk preparat inneholdende slike forbindelser, og deres anvendelse
HUP0100431A2 (hu) Adamantánszármazékok, ezeket tartalmazó gyógyászati készítmények és előállításuk
AR039564A1 (es) Derivados de carbonilamino como inhibidores de desacetilasa de histona, composiciones farmaceuticas y procesos de preparacion del compuesto y de las composiciones que lo contienen
BRPI0616799B8 (pt) derivado de piridina e derivado de pirimidina, composições farmacêuticas, usos, inibidores de angiogênese, contra receptor de fator de crescimento de hepatócito e contra metástase de câncer, e agente antitumor
YU45095A (sh) Derivati benzimidazola, postupci za njihovo prirpremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija
HUP0203323A2 (hu) Tirozin kináz inhibitorok és ilyen vegyületeket tartalmazó gyógyászati készítmények
HUP0301382A2 (hu) Alfa-aril-etanol-amin-származékok és e vegyületeket tartalmazó béta-3 adrenergiás receptor agonista hatású gyógyászati készítmények
HUP0303756A2 (hu) 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
EA200601178A1 (ru) Морфолинилсодержащие бензимидазолы в качестве ингибиторов репликации респираторно-синцитиального вируса
HUP0400558A2 (hu) Helyettesített benzolszármazékok, illetve sóik és ezeket tartalmazó gyógyszerkészítmények
BR0308696A (pt) Derivados de quinolina e seu emprego como ligante de 5-ht6
MEP7808A (en) Process for preparing 4-trifluoromethylsulphinylpyrazole derivative
MX2019012336A (es) Compuestos inhibidores del transportador vesicular de monoaminas 2 (vmat2) y composiciones de los mismos.
FI941987A (fi) Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset
CA2451980A1 (en) 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune disorders
GB1088973A (en) Indazole derivatives
NO20001402L (no) Substituerte kromanderivater
YU40998A (sh) Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
PA8573501A1 (es) Derivados de benzoxazina y su empleo